What did @gretchenfullidoofficial actually say?
Gretchen said she uses a daily injectable stack of BPC-157 and TB-500 (the so-called Wolverine Stack) plus GHK-Cu copper peptide for "tissue regeneration, muscle recovery, and inflammation control," along with "collagen production, skin regeneration, improved elasticity, and overall texture." She said she consulted a doctor and ran blood tests before starting.
To her credit, she did not promise a cure, did not give a dose, and explicitly framed this as personalized to her goals. That kind of framing is more responsible than most peptide content on TikTok. But she also dropped a specific clinic name and implied these results are broadly accessible, which raises real questions about what viewers are actually hearing.
Does the science back this up?
Partially, but far less than this video implies. The human data on injectable BPC-157 and TB-500 is thin to nonexistent, and that gap matters enormously when you are talking about daily injections.
BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide derived from a protein found in gastric juice. Animal studies, primarily in rats, have shown accelerated tendon and ligament healing and some anti-inflammatory effects (Sikiric et al., 2018, Current Pharmaceutical Design). Those findings are real. The problem is that no completed, peer-reviewed human clinical trials have demonstrated equivalent effects in people. The jump from rat tendon healing to "muscle recovery" in a human athlete is a large, unproven leap.
TB-500 (Thymosin Beta-4) has a similarly lopsided evidence base. Animal and in vitro research suggests roles in actin regulation and wound healing (Goldstein and Kleinman, 2015, Annals of the New York Academy of Sciences), but again, robust human trial data does not exist. The FDA has not approved either compound for any indication.
GHK-Cu (copper peptide) has a more established cosmetic literature behind it. Studies by Pickart and Margolina (2018, Cosmetics) documented effects on fibroblast stimulation and collagen synthesis in cell culture models. The claim about improved skin elasticity is better supported than the Wolverine Stack claims, though most evidence still comes from topical use, not injection.
What did they get wrong (or right)?
Right: recommending blood work before starting, working with a physician, and framing outcomes as personalized rather than universal. Those are legitimate safety practices.
Wrong, or at least overstated: describing BPC-157 and TB-500 as established tools for "tissue regeneration" and "inflammation control" as if the human evidence is settled. It is not. Gretchen says this stack is "a good thing for me because I work out a lot," but there is no published human data showing that daily injectable BPC-157 or TB-500 meaningfully improves recovery in otherwise healthy athletes.
Also worth flagging: both BPC-157 and TB-500 are on the World Anti-Doping Agency prohibited list for in-competition use. That is not a minor footnote for someone promoting these compounds to a fitness audience.
- BPC-157 is not FDA-approved and has no completed phase II or III human trials.
- TB-500 is prohibited in competitive sport under WADA regulations.
- GHK-Cu has the strongest cosmetic evidence of the three, but most studies are in vitro or topical.
What should you actually know?
If you are considering any of these peptides, the most honest thing to say is: the human safety profile for long-term daily injectable use is genuinely unknown. That does not mean they are definitively dangerous, but it does mean the risk calculus is different from, say, a well-studied supplement.
Compounded peptides sourced from specialty clinics like the one named in this video are not equivalent to FDA-approved pharmaceuticals. Purity, sterility, and dosing accuracy in compounded preparations vary, and that variability is a real concern with injectable products.
The doctor-supervised framing is the most responsible part of this video, and viewers should take it seriously rather than treating it as a disclaimer to skip. Self-sourcing and self-injecting peptides purchased outside a licensed clinical setting carries infection risk and unknown compound quality. If these are compounds you want to explore, the conversation starts with a physician who can review your individual labs, not a TikTok stack recommendation.